Minute Insight: Illumina Seeks Stability, Names Thaysen As New CEO
Executive Summary
The genome-sequencing giant has named Jacob Thaysen, who brings extensive experience from Agilent, as its new leader.
You may also be interested in...
Minute Insight: Guardant And Illumina Resolve Litigation, Agree To Partnership
Illumina sued Guardant last year, claiming Guardant’s founders stole trade secrets related to blood biopsy diagnostics. The companies have agreed to drop that dispute and share specimen samples for cancer research.
Illumina Creeps Closer To Half-Billion-Dollar Fine
The sequencing giant could be pilloried in Europe and may have to pay a record-breaking fine.
CEO Resignation Raises Doubts About Illumina’s Commitment To Grail
Francis deSouza resigned as CEO and chairman of Illumina just a few weeks after winning the support of shareholders. General counsel Charles Dadswell will take over as interim CEO.